Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Finasteride may help treat childhood brain tumors by activating certain genes.

Triamcinolone acetonide injections help hair regrow quickly in mild alopecia but not in severe cases.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Interferon β from hair cells stops the growth of other hair cells.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Ritlecitinib can help about 14,000 people with severe hair loss.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.